These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 25150866)

  • 1. Diagnostic procedures for paraffin-embedded tissues analysis in pharmacogenomic studies.
    Palmirotta R; De Marchis ML; Ludovici G; Ferroni P; Abete P; Guadagni F; Della-Morte D
    Methods Mol Biol; 2014; 1175():45-65. PubMed ID: 25150866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
    Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
    Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically relevant cancer biomarkers and pharmacogenetic assays.
    Patel JN; Mandock K; McLeod HL
    J Oncol Pharm Pract; 2014 Feb; 20(1):65-72. PubMed ID: 23353710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy.
    Savonarola A; Palmirotta R; Guadagni F; Silvestris F
    Pharmacogenomics J; 2012 Aug; 12(4):277-86. PubMed ID: 22760589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics using Luminex® xMAP® technology: a method for developing a custom multiplex single nucleotide polymorphism mutation assay.
    Spierings G; Dunbar SA
    Methods Mol Biol; 2013; 1015():115-26. PubMed ID: 23824852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacogenetics of anticancer drugs].
    de Chaisemartin L; Loriot MA
    Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of genotype-guided cancer therapy in solid tumors.
    Patel JN
    Pharmacogenomics; 2014 Jan; 15(1):79-93. PubMed ID: 24329193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution melting analysis as a sensitive prescreening diagnostic tool to detect KRAS , BRAF , PIK3CA , and AKT1 mutations in formalin-fixed, paraffin-embedded tissues.
    Ney JT; Froehner S; Roesler A; Buettner R; Merkelbach-Bruse S
    Arch Pathol Lab Med; 2012 Sep; 136(9):983-92. PubMed ID: 22938585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic application in personalized cancer treatment.
    Kristyanto H; Utomo AR
    Acta Med Indones; 2010 Apr; 42(2):109-15. PubMed ID: 20513938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
    Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
    Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics in clinical practice: considerations for testing.
    Constable S; Johnson MR; Pirmohamed M
    Expert Rev Mol Diagn; 2006 Mar; 6(2):193-205. PubMed ID: 16512779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleic acid extraction methods from fixed and paraffin-embedded tissues in cancer diagnostics.
    Bonin S; Stanta G
    Expert Rev Mol Diagn; 2013 Apr; 13(3):271-82. PubMed ID: 23570405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic diagnostics in inflammatory dermatoses--from insights into pathophysiology to individualized patient management.
    Reich K; Blödorn-Schlicht N; Falk TM
    J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():59-67. PubMed ID: 23721645
    [No Abstract]   [Full Text] [Related]  

  • 15. Individualized drug therapy.
    Daly AK
    Curr Opin Drug Discov Devel; 2007 Jan; 10(1):29-36. PubMed ID: 17265738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman RA
    Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of microRNAs in personalized medicine.
    Avci CB; Baran Y
    Methods Mol Biol; 2014; 1107():311-25. PubMed ID: 24272446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing.
    Endris V; Penzel R; Warth A; Muckenhuber A; Schirmacher P; Stenzinger A; Weichert W
    J Mol Diagn; 2013 Nov; 15(6):765-75. PubMed ID: 23973117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the use of pharmacogenetics in cancer treatment and clinical trials.
    Robert J; Le Morvan V; Giovannetti E; Peters GJ;
    Eur J Cancer; 2014 Oct; 50(15):2532-43. PubMed ID: 25103456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening for EGFR mutations in lung cancer by a novel real-time PCR with double-loop probe and Sanger DNA sequencing].
    Zhang HP; Ruan L; Zheng LM; Bai DY; Zhang HF; Liao YQ; Ding Y
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):28-32. PubMed ID: 23648296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.